More Articles

Access and Evidence

Talking The Same Language

Adam Chapman, (Aug 10, 2018)

A universal standard for real-world evidence no longer seems quixotic. But how are companies going to do it?
Patients and Medical

Why Patient Organizations Are No Summer Fling For Pharma

Adam Chapman, (Aug 8, 2018)

Pharma companies are forming long-term relationships with patient organizations, a move that is already bearing fruits for both parties.
Access and Evidence

Going Through the Motions

Adam Chapman, (Aug 6, 2018)

Both pharma and payers say they need to talk more, but are they really listening?
Access and Evidence

Navigating the Chaos

Adam Chapman, (Aug 6, 2018)

With the access landscape shifting rapidly, pharma needs to watch its step
Patients and Medical

Flying The Flag For Patients

Hugh Gosling, (Aug 2, 2018)

The Chief Patient Officer is pharma’s face of patient-centricity but how is this relatively new role shaping up?
Access and Evidence

Seeking the Holy Grail of RWE

Adam Chapman, (Aug 2, 2018)

Universal standards for real-world evidence are closer than you might think
Patients and Medical

Five Reasons Why Clinical Trials Fail And What Pharma is Doing To Fix It

Adam Chapman, (Jul 27, 2018)

Clinical trial recruitment is a perennial challenge for pharma. Are they listening to patients?
Access and Evidence

United: How employers are changing healthcare

Hugh Gosling, (Jul 27, 2018)

The growth in employer coalitions are a sign that plan sponsors are increasingly flexing their muscles, but what do they hope to achieve?
Patients and Medical

Six Ways Artificial Intelligence Is Impacting Patients

Lucy Fulford, (Jul 24, 2018)

AI is no longer the stuff of science fiction – it’s impacting patients today
Access and Evidence

Writing the Value Story

Adam Chapman, (Jul 19, 2018)

When writing the value story for a new medicine, starting earlier in Development will make sure it’s a page-turner